This program is supported through an independent educational grant from Johnson & Johnson and Bristol Myers Squibb. It is intended exclusively for healthcare professionals globally.

In this live webinar, national cardiovascular expert Christian T. Ruff, MD, MPH provides practical, case-based insights on optimizing thrombosis management in acute coronary syndrome (ACS), atrial fibrillation (AF), and secondary stroke prevention (SSP). Drawing on the latest guidelines and clinical trial evidence, the faculty demonstrates how to apply validated risk assessment tools and tailor antithrombotic therapy to balance thrombotic and bleeding risk in high-risk patients.

Accreditation: 0.75 AMA PRA Category 1 Credit™.

This module features real-world scenarios and expert commentary—helping healthcare professionals sharpen their ability to identify high-risk patients and select the right anticoagulation strategies across diverse cardiovascular settings.

Session Highlights

• Risk tools in action: Use CHA₂DS₂-VASc, HAS-BLED, and GRACE scoring systems to stratify risk in AF, ACS, and SSP.
• Tailored treatment plans: Optimize DOAC selection and dosing based on patient-specific thrombotic and bleeding risks.
• Avoid the risk-treatment paradox: Improve adherence to evidence-based strategies while addressing bleeding concerns.
• Real-world learning: Apply case-based decision-making to common clinical challenges.

Who Should Watch

• Cardiologists
• Electrophysiologists
• Interventional Cardiologists
• Cardiac Surgeons
• Primary Care Physicians
• Nurse Practitioners
• Physician Assistants
• Other U.S.-based HCPs managing thrombosis in AF, ACS, or stroke

Presented by

Christian T. Ruff, MD, MPH - is the Director of General Cardiology at Brigham and Women’s Hospital and an Assistant Professor of Medicine at Harvard Medical School. He graduated from Harvard University with a degree in Neurobiology and earned his medical degree at Johns Hopkins University School of Medicine. Dr Ruff is an investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group and serves as the Director of the Genetics Core Laboratory and as Co-Director of the Clinical Events Committee. He has specific expertise in atrial fibrillation, risk stratification and implementation of antithrombotic therapy for stroke prevention, as well as the treatment and prevention of venous thromboembolism.

Tom Buffolano – is a two-time pulmonary embolism survivor and a dedicated patient advocate. He joined the National Blood Clot Alliance Board to ensure that the blood clot community receives the education and support they deserve. With over 40 years as an endurance athlete, including completing a sub-3-hour marathon, Tom has coached hundreds of runners and cyclists, inspiring many to begin exercising for the first time.

Continuing Education Information

This continuing education activity will be provided by Current Concepts Institute (CCI) and MedAll. Physicians, Nurse Practitioners, and Physician Assistants will be eligible for AMA PRA Category 1 Credit™; Nurses for ANCC Contact Hours. A statement of participation is available for other healthcare professionals.

Unapproved and/or off-label use disclosure

Current Concepts Institute/MedAll requires CE faculty to disclose to the participants:

1. When products or procedures being discussed are off-label, unlabelled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and

2. Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

Disclosures

Below is a listing of all individuals who are involved in the planning and implementation of this accredited continuing education activity. All relevant financial relationships listed for these individuals have been mitigated.

Dr. Christian T. Ruff has disclosed financial relationships within the past 24 months with the following ineligible companies. He has received grants through his institution from Anthos, AstraZeneca, Daiichi Sankyo, Janssen, and Novartis. He has also received honoraria for participation on scientific advisory boards and consulting from Daiichi Sankyo, Janssen, Pfizer, Anthos, Bayer, and Bristol Myers Squibb. These disclosures are made in accordance with ACCME standards to ensure transparency and objectivity in continuing education. His presentation includes reference to non-FDA uses of drug products and/or devices and their unlabelled indications. We will disclose to the audience when this discussion takes place.

Tom Buffolano does not have any financial interests with ineligible companies to disclose.

CCI staff, MedAll staff, and all planners and reviewers have no relevant financial relationships with ineligible companies to disclose.

Activity Accreditation for Health Professions

Physicians

AMA PRA Category 1 Credits™ are available for this activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Current Concepts Institute and MedAll Education. Current Concepts Institute is accredited by the ACCME to provide continuing medical education for physicians.

Current Concepts Institute designates this online activity a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This continuing education activity is active starting 31st November 2025 and will expire on 31st November 2025. Estimated time to complete this activity: 45 minutes.

Other Professionals

All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

How to Earn Your CME Credit:

To earn your certificate, attend the full webinar and complete the post-session assessment. A link to your certificate will be provided upon completion.

Participation Costs

There is no cost to participate in this program.